NSPR 10-Q: SEC filing
InspireMD, Inc.
Filed with the SEC on · accession 0001493152-26-052402
NSPR filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -6.8% by the first close after the filing.
Summary of the filing
InspireMD, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosures including a September 2026 warrant issuance (Series J and K warrants).
Key details
How NSPR stock reacted
Close before
$0.64
Nov 13, 2026
First close after
-6.85%
$0.60
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for NSPR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NSPR?
Click hereFrequently asked questions
What did NSPR file with the SEC on Nov 16, 2026?
NSPR filed a 10-Q (SEC filing). InspireMD, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosures including a September 2026 warrant issuance (Series J and K warrants).
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did NSPR stock react to this filing?
NSPR closed at $0.64 before the filing and $0.60 on Nov 16, 2026 (-6.85%).
Other NSPR SEC filings
- 424B5 · Secondary offeringNov 16, 2026
- 8-K · Secondary offeringNov 16, 2026
- 424B5 · Secondary offeringNov 12, 2026
- 8-K · SEC filingNov 12, 2026
- 8-K · Fda approvalNov 12, 2026
- 8-K · Material agreementSep 21, 2026
- 8-K · SEC filingAug 17, 2026
- 10-Q · SEC filingAug 14, 2026
- 8-K · Executive departureJul 29, 2026
- 8-K · Delisting noticeJul 23, 2026
Get alerts when NSPR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days